Miami, Florida, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), through a licensing partnership with The Jenex Corporation (Jenex, NEX: JEN.H) will market, promote and distribute Jenex’s new thermal therapy insect device under the trade name TherOZap™.
TherOZap™ utilizes advanced thermal technology to provide relief from insect bites and stings. Rob Fia, Jenex CEO & Chairman comments: “TherOZap™ will offer consumers effective relief through an efficient and user-friendly experience."
“We are very pleased with the pace of product development at Jenex and encouraged by the potential for TherOZap™." adds Luminar's CEO Chris Cook. "We are working closely with Jenex and expect to bring this novel solution to market in early 2017.”
Market Data 
Markets 
AI
